“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: PEG-asparaginase in the treatment of childhood acute lymphoblastic leukaemia

€3.03

SKU: product-article-14140 Category: General

Description
Reviews (0)

Description

PEG-asparaginase in the treatment of childhood acute lymphoblastic leukaemia

Reviews

There are no reviews yet.

Be the first to review “Article: PEG-asparaginase in the treatment of childhood acute lymphoblastic leukaemia”

You must be logged in to post a review.

Top

Article: PEG-asparaginase in the treatment of childhood acute lymphoblastic leukaemia

Description

Reviews

Related products

Article: INTRODUCTION

Article: Highlights in genitourinary cancers

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in melanoma